These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2952126)
41. Structure-activity relationships for the inhibition of plasmin and plasminogen activation by aromatic diamidines and a study of the effect of plasma proteins on the inhibition process. Geratz JD Thromb Diath Haemorrh; 1973 Feb; 29(1):154-67. PubMed ID: 4267737 [No Abstract] [Full Text] [Related]
42. p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases. Evans SA; Olson ST; Shore JD J Biol Chem; 1982 Mar; 257(6):3014-7. PubMed ID: 7037776 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of the haemolytic complement activity by derivatives of benzamidine. Hauptmann J; Markwardt F Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323 [No Abstract] [Full Text] [Related]
44. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases. Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of bisbenzamidines as inhibitors for matriptase-2. Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367 [TBL] [Abstract][Full Text] [Related]
46. Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin. Tidwell RR; Geratz JD; Dubovi EJ J Med Chem; 1983 Feb; 26(2):294-8. PubMed ID: 6219223 [TBL] [Abstract][Full Text] [Related]
51. A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin. Katakura S; Nagahara T; Hara T; Iwamoto M Biochem Biophys Res Commun; 1993 Dec; 197(2):965-72. PubMed ID: 8267636 [TBL] [Abstract][Full Text] [Related]
52. Alpha-1-antitrypsin. 3. Inhibition of trypsin, thrombin, plasmin and leucoproteinases. Tan BH; Gans H Pharm Weekbl; 1969 Jun; 104(26):717-25. PubMed ID: 4239740 [No Abstract] [Full Text] [Related]
54. Specific adsorption of serine proteases on coated silica beads substituted with amidine derivatives. Khamlichi S; Muller D; Fuks R; Jozefonvicz J J Chromatogr; 1990 Jun; 510():123-32. PubMed ID: 2169476 [TBL] [Abstract][Full Text] [Related]
55. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase. Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114 [TBL] [Abstract][Full Text] [Related]
56. [Synthetic inhibitors of serine proteinases. 18. Inhibition of trypsin, plasmin and thrombin by derivatives of naphthamidine and ketone structure]. Walsmann P; Markwardt F; Stürzebecher J; Voigt B; Wagner G Pharmazie; 1978 Nov; 33(11):760-1. PubMed ID: 155823 [No Abstract] [Full Text] [Related]
57. Inhibition of batroxobin, a serine proteinase from Bothrops snake venom, by derivatives of benzamidine. Stürzebecher J; Stürzebecher U; Markwardt F Toxicon; 1986; 24(6):585-95. PubMed ID: 3529503 [TBL] [Abstract][Full Text] [Related]
58. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes. Markwardt F; Klöcking HP Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748 [TBL] [Abstract][Full Text] [Related]